News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
589,575 Results
Type
Article (21553)
Company Profile (321)
Press Release (567782)
Multimedia
Podcasts (114)
Webinars (16)
Section
Business (195910)
Career Advice (550)
Deals (30079)
Drug Delivery (56)
Drug Development (71743)
Employer Resources (49)
FDA (12476)
Job Trends (10717)
News (287655)
Policy (22610)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1323)
Accelerated approval (43)
ADA (38)
Adcomms (16)
Allergies (150)
Alliances (41703)
ALS (214)
Alzheimer's disease (1516)
Antibody-drug conjugate (ADC) (532)
Approvals (13053)
Artificial intelligence (600)
ASCO (274)
Autoimmune disease (343)
Automation (42)
Bankruptcy (300)
Best Places to Work (8624)
BIO (65)
BIOSECURE Act (6)
Biosimilars (178)
BioSpace Insights (89)
Biotechnology (228)
Bladder cancer (178)
Brain cancer (64)
Breast cancer (688)
Cancer (5601)
Cardiovascular disease (410)
Career advice (475)
Career pathing (17)
CAR-T (328)
CDC (9)
Celiac Disease (1)
Cell therapy (905)
Cervical cancer (43)
Clinical research (63768)
Collaboration (2069)
Commercialization (6)
Company closure (3)
Compensation (1553)
Complete response letters (77)
COVID-19 (1543)
CRISPR (125)
C-suite (1158)
Cystic fibrosis (144)
Data (7989)
Denatured (26)
Depression (164)
Dermatology (93)
Diabetes (502)
Diagnostics (4973)
Digital health (46)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (357)
Drug pricing (61)
Drug shortages (5)
Duchenne muscular dystrophy (324)
Earnings (81091)
Editorial (37)
Employer branding (6)
Employer resources (45)
Events (104076)
Executive appointments (998)
FDA (16031)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1676)
Gene editing (263)
Generative AI (47)
Gene therapy (729)
GLP-1 (695)
Government (1929)
Grass and pollen (4)
Guidances (341)
Healthcare (12305)
Hematology (148)
HIV (69)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (108)
Immunology and inflammation (281)
Immuno-oncology (99)
Indications (212)
Infectious disease (1811)
Inflammatory bowel disease (207)
Inflation Reduction Act (12)
Influenza (101)
Intellectual property (310)
Interviews (83)
IPO (14484)
IRA (13)
Job creations (2458)
Job search strategy (415)
JPM (42)
Kidney cancer (19)
Labor market (41)
Layoffs (316)
Leadership (21)
Legal (5676)
Licensing (10)
Liver cancer (66)
Longevity (31)
Lung cancer (759)
Lymphoma (405)
Machine learning (49)
Management (14)
Manufacturing (851)
Marketing (12)
MASH (187)
Medical affairs (1)
Medical device (10209)
Medtech (10376)
Mergers & acquisitions (16818)
Metabolic disorders (1242)
mRNA (194)
Multiple sclerosis (161)
NASH (14)
Neurodegenerative disease (442)
Neuropsychiatric disorders (100)
Neuroscience (3047)
Neurotech (1)
NextGen: Class of 2026 (4216)
Non-profit (1634)
Now hiring (44)
Obesity (518)
Opinion (183)
Ovarian cancer (225)
Pain (232)
Pancreatic cancer (315)
Parkinson's disease (376)
Partnered (25)
Patents (594)
Patient recruitment (779)
Peanut (56)
People (49897)
Pharmaceutical (51)
Pharmacy benefit managers (13)
Phase 1 (21041)
Phase 2 (28797)
Phase 3 (19552)
Pipeline (9716)
Policy (126)
Postmarket research (1898)
Preclinical (9009)
Press Release (54)
Prostate cancer (294)
Psychedelics (75)
Radiopharmaceuticals (345)
Rare diseases (1116)
Real estate (3838)
Recruiting (20)
Regulatory (19749)
Reports (33)
Research institute (1408)
Resumes & cover letters (77)
Rett syndrome (48)
RNA editing (32)
RSV (58)
Schizophrenia (173)
Series A (311)
Series B (223)
Service/supplier (5)
Sickle cell disease (117)
Special edition (21)
Spinal muscular atrophy (145)
Sponsored (28)
Startups (3146)
State (1)
Stomach cancer (8)
Supply chain (76)
Tariffs (22)
The Weekly (86)
Vaccines (600)
Venture capital (105)
Weight loss (267)
Women's health (102)
Worklife (5)
Date
Today (76)
Last 7 days (467)
Last 30 days (2187)
Last 365 days (26159)
2026 (16749)
2025 (26017)
2024 (30360)
2023 (34365)
2022 (43771)
2021 (46409)
2020 (41693)
2019 (30556)
2018 (22972)
2017 (24588)
2016 (23070)
2015 (29332)
2014 (25203)
2013 (20936)
2012 (22800)
2011 (23028)
2010 (22595)
Location
Africa (363)
Alabama (94)
Alaska (4)
Arizona (338)
Arkansas (14)
Asia (29397)
Australia (4589)
California (13764)
Canada (3743)
China (1335)
Colorado (566)
Connecticut (534)
Delaware (371)
Europe (56262)
Florida (2008)
Georgia (418)
Hawaii (4)
Idaho (48)
Illinois (941)
India (84)
Indiana (445)
Iowa (18)
Japan (541)
Kansas (116)
Kentucky (36)
Louisiana (42)
Maine (37)
Maryland (1473)
Massachusetts (9941)
Michigan (320)
Minnesota (656)
Mississippi (5)
Missouri (96)
Montana (32)
Nebraska (16)
Nevada (132)
New Hampshire (75)
New Jersey (3210)
New Mexico (19)
New York (3396)
North Carolina (1692)
North Dakota (9)
Northern California (7054)
Ohio (345)
Oklahoma (16)
Oregon (35)
Pennsylvania (2681)
Puerto Rico (24)
Rhode Island (38)
South America (560)
South Carolina (77)
South Dakota (1)
Southern California (5470)
Tennessee (148)
Texas (2203)
United States (46630)
Utah (402)
Vermont (1)
Virginia (248)
Washington D.C. (52)
Washington State (1108)
West Virginia (2)
Wisconsin (109)
Wyoming (1)
589,575 Results for "adaptive phage therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
July 29, 2026
·
14 min read
Press Releases
Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma
August 11, 2026
·
5 min read
Press Releases
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
July 9, 2026
·
1 min read
Deals
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
BiomX Inc. today announced that it has entered into a definitive merger agreement with Adaptive Phage Therapeutics, Inc. (“APT”), a U.S.-based privately-held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections (the “Acquisition”).
March 6, 2024
·
15 min read
Press Releases
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
June 15, 2026
·
5 min read
Press Releases
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
June 17, 2026
·
11 min read
Press Releases
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - May 21, 2026
May 22, 2026
·
1 min read
Press Releases
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering - June 15, 2026
June 15, 2026
·
9 min read
Press Releases
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
May 6, 2026
·
13 min read
Deals
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
BiomX Inc. announced the closing of its previously announced acquisition of Adaptive Phage Therapeutics, Inc. and its previously announced $50 million private placement to certain institutional accredited investors, which was led by affiliates of Deerfield Management Company and the AMR Action Fund, and additional investors including the Cystic Fibrosis Foundation, OrbiMed and Nantahala Capital.
March 18, 2024
·
11 min read
1 of 58,958
Next
